https://www.avient.com/products/long-fiber-technology/long-vs-short-fiber
0.12 in/3 mm diameter
Pellets typically 0.12 in/3 mm long
https://www.avient.com/knowledge-base/case-study/military-grade-protection-us-soldiers?rtype[]=1164
The MPS incorporates Avient’s custom-formulated GlasArmor ballistic panels that meet Level 3 protection under Underwriters Laboratories (UL) 752 standards for ballistic resistance.
Level 3 ensures protection against a .44 magnum lead semi-wadcutter gas-checked projectile.
https://www.avient.com/knowledge-base/case-study/military-grade-protection-us-soldiers?ind[]=6595
The MPS incorporates Avient’s custom-formulated GlasArmor ballistic panels that meet Level 3 protection under Underwriters Laboratories (UL) 752 standards for ballistic resistance.
Level 3 ensures protection against a .44 magnum lead semi-wadcutter gas-checked projectile.
https://www.avient.com/news/polyone-‘driving’-advanced-polymer-solutions-future-vehicles-piae-2019
April 3, 2019
MANNHEIM, Germany – April 3, 2019 – This week at the Plastics in Automotive Engineering (PIAE) congress, PolyOne is presenting its deep portfolio of advanced polymers, colorants, and additives that help automotive manufacturers keep pace with changes in technology and consumer demand.
https://www.avient.com/news/polyone-develops-new-silicone-alternative-tpe-medical-tubing
February 3, 2020
ANAHEIM, Calif. – February 3, 2020 – At Medical Design and Manufacturing (MD&M) West next week, PolyOne will launch its newest medical grade, Versaflex™ HC BT218, formulated in response to supply challenges stemming from silicone shortages and sterilization facility closures.
https://www.avient.com/news/polyone-features-more-materials-approach-medical-devices-mdm-west-2020
February 3, 2020
ANAHEIM, Calif. – February 3, 2020 – At Medical Design and Manufacturing (MD&M) West next week, PolyOne is focusing on helping customers solve pressing medical device challenges through a “More Than Materials” approach.
https://www.avient.com/sites/default/files/2022-05/Compensation Committee Charter (REV 10-2019).pdf
Microsoft Word - Compensation Committee Charter (REV 10-2019)3[1].docx AVIENT CORPORATION COMPENSATION COMMITTEE CHARTER Membership • The Committee will consist entirely of directors who meet the definition of “independent” as set forth in the Corporate Governance Standards of the New York Stock Exchange, including the additional independence requirements set forth in New York Stock Exchange Listed Company Manual Section 303A.02(a)(ii). • Members of the Committee will be appointed by the Board each year following the annual meeting of shareholders. • Each Committee member will serve at the pleasure of the Board for such term as the Board may decide or until such Committee member is no longer a Board member. • The Committee shall consist of a minimum of three directors. • The Committee will select a Committee Chair from among its members.
Duties and Responsibilities The Committee will: Executive Compensation and Incentives. • Develop and maintain a competitive executive compensation program in order to attract and retain qualified executives and to provide incentives to management that reward pay for performance in attaining the Company’s goals and objectives. 2 • Review and approve a peer group of companies to be used for marketplace trend analysis and to assess the competitiveness of the Company’s total compensation opportunities for executive officers. • Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by the independent compensation consultant. • In determining the long-term incentive component of the Chief Executive Officer’s compensation, consider the Company’s performance and relative shareholder return, the value of similar incentive awards to chief executive officers at comparable companies, and the awards given to the Chief Executive Officer in the past. • Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate. • In evaluating and making recommendations regarding, or determining and approving, executive compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation (“Say on Pay Vote”) required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). • With respect to incentive compensation plans and equity-based plans: • Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • Review and approve equity-based grants and awards, including long-term incentive plan awards, to officers, senior managers, key employees, and other employees of the Company and its subsidiaries under the Company’s equity-based plans. • Review and approve the performance criteria, target awards, payout criteria and like items for the Company’s annual incentive and long-term incentive compensation plans. • Review and approve (a) attainment levels under the Company’s annual incentive plan; (b) payments to executive officers of the Company under the annual incentive plan; and (c) payments to officers, senior managers and employees of the Company under the Company’s long-term incentive compensation plans. • Administer the Company’s equity-based incentive compensation plans and other plans adopted by the Board that contemplate administration by the Committee. • Review and approve special bonuses and/or other awards to executive officers on a case-by- case basis for outstanding performance. • Review and approve the terms of all employment agreements, management continuity agreements and change in control agreements for elected officers. 3 Non-employee Director Compensation. • Review the compensation of non-employee directors and make recommendations to the Board regarding changes to existing compensation levels. • Perform administrative functions with respect to the compensation of non-employee directors, including interpreting existing policy. • Review and approve (or approve and recommend to the Board for its approval) equity-based grants and awards to non-employee directors under the Company’s equity-based plans.
Independence Assessment of Outside Advisers • The Committee may select a compensation consultant, legal counsel or other adviser to the Committee or receive advice from a compensation consultant, legal counsel or other adviser (other than in-house legal counsel or any compensation consultant, legal counsel or other adviser whose role is limited to the following activities for which no disclosure would be required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan that does not discriminate in scope, terms, or operation, in favor of executive officers or directors of the Company, and that is available generally to all salaried employees; or providing information that either is not customized for a particular company or that is customized based on parameters that are not developed by the compensation consultant, and about which the compensation consultant does not provide advice) only after taking into consideration all factors relevant to that person’s independence from management, including the following: • the provision of other services to the Company by the employer of the compensation consultant, legal counsel or other adviser; 5 • the amount of fees received from the Company by the employer of the compensation consultant, legal counsel or other adviser, as a percentage of the total revenue of the employer of the compensation consultant, legal counsel or other adviser; • the policies and procedures of the employer of the compensation consultant, legal counsel or other adviser that are designed to prevent conflicts of interest; • any business or personal relationship of the compensation consultant, legal counsel or other adviser with a member of the Committee; • any stock of the Company owned by the compensation consultant, legal counsel or other adviser; and • any business or personal relationship of the compensation consultant, legal counsel, other adviser or the employer of the adviser with an executive officer of the Company. • The Committee shall evaluate whether any compensation consultant retained or to be retained by it has any conflict of interest in accordance with Item 407(e)(3)(iv) of Regulation S-K.
https://www.avient.com/sites/default/files/2022-08/Schedule 2 a_b_c - SCCs_0.pdf
Clause 1, Clause 2, Clause 3, Clause 6, Clause 7; ii.
Updated 08/04/2022 3 b.
Clause 3 Third-party beneficiaries a.
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-english.pdf
Avient’s legal department will help you protect yourself and the Company should questions later arise. 3.
Avoid even the appearance of any such agreement and avoid circumstances where such agreements could occur. 3.
Document the incident, including answers to the following: who was present at the meeting, when and where the meeting occurred, and what happened at the meeting. 8.
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2020-results
8:00 a.m.
Attachment 3
Tax adjustments (Attachment 3)